Comprehensive analysis of POLH-AS1 as a prognostic biomarker in hepatocellular carcinoma
POLH-AS1 emerges as a promising prognostic biomarker and therapeutic target for HCC, offering potential avenues for enhanced patient management and treatment strategies.
Authors
- Liangyu Wang (ORCID: https://orcid.org/0000-0001-5264-1502)
- Xueping Gao (ORCID: https://orcid.org/0000-0002-6611-8373)
- Lixia Xu (ORCID: https://orcid.org/0000-0002-1818-6267)
- Di Chen (ORCID: https://orcid.org/0000-0002-2181-4703)
- Xinyi Chen (ORCID: https://orcid.org/0000-0002-0638-1380)
- Yan Dong (ORCID: https://orcid.org/0000-0002-6231-1942)
- Yilong Fu
- Yang Shen (ORCID: https://orcid.org/0000-0003-4714-0839)
Institutions
- Sun Yat-sen University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Sun Yat-sen University Cancer Center (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1186/s12885-024-12857-8
- Citations
- 3
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.70